Floatz logo

VITAMIN D

Pancreas Cancer

Medical University of GrazmixturePhase 3Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

82 Active assets in the Pancreas Cancer cohort.

Asset / SponsorPhaseRating
Epirubicin
TME Pharma AG
Phase 3BB
Pembrolizumab
Essen Biotech
Phase 2BB
Surufatinib
Tianjin Medical University Cancer Institute and Hospital
Phase 3BB
PANITUMUMAB
SWOG Cancer Research Network
Phase 3BB
Docetaxel
Minia University
Phase 3BB

View all 50 →

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →